Abstract
A capillary hemangioma is a vascular tumor with small capillary sized vascular channel. Multiple capillary hemangioma in relation with drugs have been rarely reported. Here in, we report a case of multiple capillary hemangioma in patient diagnosed with chronic myeloid leukemia who received tyrosine kinase inhibitors (TKIs). Histopathological findings have shown capillary proliferation in the upper dermis, which is consistent with capillary hemangioma. Since TKIs can paradoxically activate the MEK/ERK pathway which is required for angiogenesis, we presumed that the lesions as the cutaneous side effects of TKIs.
| Original language | English |
|---|---|
| Pages (from-to) | 278-280 |
| Number of pages | 3 |
| Journal | Annals of Dermatology |
| Volume | 33 |
| Issue number | 3 |
| DOIs | |
| State | Published - Jun 2021 |
UN SDGs
This output contributes to the following UN Sustainable Development Goals (SDGs)
-
SDG 3 Good Health and Well-being
Keywords
- Capillary hemangioma
- Chronic myeloid leukemia
- Dasatinib
- Imatinib
- Nilotinib
Fingerprint
Dive into the research topics of 'A case report of multiple capillary hemangioma in a chronic myeloid leukemia patient taking tyrosine kinase inhibitors'. Together they form a unique fingerprint.Cite this
- APA
- Author
- BIBTEX
- Harvard
- Standard
- RIS
- Vancouver